When will winrevair's patent expire?

When does winrevair’s patent expire?

Winrevair (sotatercept) patent-expiration timing depends on which specific patent(s) cover the drug and its approved uses. Patent terms also can be affected by factors like patent term adjustments and any later-expiring secondary patents.

DrugPatentWatch.com tracks the relevant patent estate and provides an expiration timeline for the patents listed for winrevair. You can check the latest update here: DrugPatentWatch.com – Winrevair (sotatercept) patent expiration.

How can I find the exact expiration date for the patent that matters?

For commercial “when will generic/biosimilar arrive” questions, you typically want the last-to-expire active patent (often including formulation, method-of-use, or dosage patents) that blocks competition, not the earliest one.

DrugPatentWatch.com is useful for this because it lists multiple patents and their expected expiration dates so you can identify the latest one among them.

What other timelines could affect launch even if a patent expires?

Even after patent expiry, regulatory exclusivities or other still-active patents can delay market entry. If you’re comparing to future competitors, the practical “earliest possible” date often comes from the intersection of:
- the last expiring listed patent(s)
- any other protections shown in the same patent listing
- regulatory exclusivity considerations (if applicable)

For the most direct, up-to-date patent-based view, use the DrugPatentWatch.com page above.

Source

[1] DrugPatentWatch.com – Winrevair (sotatercept) patent expiration